News
-
EpiVax Oncology Appoints CTO & BOD Member
EpiVax Oncology, Inc., a precision cancer immunotherapy company, is pleased to announce the appointment of Dominique Bridon as…
Read more -
Chicago Bar Foundation & Paladin Announce Groundbreaking Partnership
In anticipation of Pro Bono Week later this month, The Chicago Bar Foundation is partnering with an innovative…
Read more -
ENB Therapeutics Closes Series A Round of Funding
ENB Therapeutics Inc., a biopharmaceutical company pioneering pathways in endothelin-based oncologics, today announced that it has closed its…
Read more -
Fund Invests in LI Pharma Startup Targagenix
Accelerate NY Seed fund invested $100,000 in cancer drug developer TargaGenix Inc. The company is commercializing a novel…
Read more -
MyMee in Dreamit HealthTech’s new cohort
MyMee is part of the fall 2018 class of DreamIt Ventures’s HealthTech program. During the 14-week program, which…
Read more -
Dentons and Paladin partner to promote pro bono innovation
Dentons, the world’s largest law firm, today announced a partnership with Paladin, a pro bono platform with a…
Read more